US FDA extends review of Humacyte's blood vessel implant

Humacyte

09/08/2024 21:14

Aug 9 (Reuters) - Humacyte  HUMA.O  said on Friday the
U.S. Food and Drug Administration has extended its review of the
company's implant that can act as a replacement for an injured
or damaged blood vessel.
    The health regulator needed additional time to complete its
review and did not disclose a new decision date, the company
said.

 (Reporting by Christy Santhosh; Editing by Shilpi Majumdar)
 ((Christy.Santhosh@thomsonreuters.com))